Format
Sort by

Send to:

Choose Destination

Search results

Items: 4

1.

Ivabradine in stable coronary artery disease without clinical heart failure.

Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R; SIGNIFY Investigators.

N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31.

2.

[Cardiovascular complications at 1-year of follow-up in patients with atherothrombosis. On behalf of Spain's REACH Registry].

Suárez C, Castillo J, Esmatjes E, Sala J, Cairols M, Montoto C, Barberá G; en representación de los investigadores del registro REACH España.

Med Clin (Barc). 2009 Apr 18;132(14):537-44. doi: 10.1016/j.medcli.2008.11.033. Spanish.

PMID:
19393390
3.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators.

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

PMID:
18757088
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk